137 related articles for article (PubMed ID: 18162511)
1. Regulation of CD28 expression on CD8+ T cells by CTLA-4.
Berg M; Zavazava N
J Leukoc Biol; 2008 Apr; 83(4):853-63. PubMed ID: 18162511
[TBL] [Abstract][Full Text] [Related]
2. Involvement of CTLA-4 in T-cell anergy induced by staphylococcal enterotoxin A in vitro.
Xu GL; Zhu XH; Guo B; Wu YZ
Mol Immunol; 2004 May; 41(1):1-8. PubMed ID: 15140570
[TBL] [Abstract][Full Text] [Related]
3. B7+ iris pigment epithelial cells convert T cells into CTLA-4+, B7-expressing CD8+ regulatory T cells.
Sugita S; Keino H; Futagami Y; Takase H; Mochizuki M; Stein-Streilein J; Streilein JW
Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5376-84. PubMed ID: 17122127
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of T cell proliferation by cholera toxin involves the modulation of costimulatory molecules CTLA-4 and CD28.
Vendetti S; Riccomi A; Sacchi A; Sciaraffia E; Gatta L; Pioli C; De Magistris MT
Immunol Lett; 2008 Jan; 115(1):59-69. PubMed ID: 18031829
[TBL] [Abstract][Full Text] [Related]
5. The CD4+CD25 bright regulatory T cells and CTLA-4 expression in peripheral and decidual lymphocytes are down-regulated in human miscarriage.
Jin LP; Chen QY; Zhang T; Guo PF; Li DJ
Clin Immunol; 2009 Dec; 133(3):402-10. PubMed ID: 19766059
[TBL] [Abstract][Full Text] [Related]
6. CD40L, CD28, and CTLA-4 expression on CD4+ T cells in kidney graft recipients: a relationship with post-transplantation clinical course.
Kosmaczewska A; Magott-Procelewska M; Frydecka I; Ciszak L; Bocko D; Szteblich A; Kusnierczyk P; Patrzalek D; Szyber P; Klinger M
Transpl Immunol; 2006 Jun; 16(1):32-40. PubMed ID: 16701174
[TBL] [Abstract][Full Text] [Related]
7. A mutant B7-1/Ig fusion protein that selectively binds to CTLA-4 ameliorates anti-tumor DNA vaccination and counters regulatory T cell activity.
Chakrabarti R; Zhou ZF; Chang Y; Prud'homme GJ
Vaccine; 2005 Aug; 23(37):4553-64. PubMed ID: 15919138
[TBL] [Abstract][Full Text] [Related]
8. Spatiotemporal basis of CTLA-4 costimulatory molecule-mediated negative regulation of T cell activation.
Yokosuka T; Kobayashi W; Takamatsu M; Sakata-Sogawa K; Zeng H; Hashimoto-Tane A; Yagita H; Tokunaga M; Saito T
Immunity; 2010 Sep; 33(3):326-39. PubMed ID: 20870175
[TBL] [Abstract][Full Text] [Related]
9. Inhibiting the expression of CD28 costimulatory molecule on human lymphocytes by special siRNA.
Xu KL; Zhang Y; Pan XY; Lu QX
Chin Med J (Engl); 2005 Mar; 118(6):480-6. PubMed ID: 15788129
[TBL] [Abstract][Full Text] [Related]
10. Synergistic induction of CTLA-4 expression by costimulation with TCR plus CD28 signals mediated by increased transcription and messenger ribonucleic acid stability.
Finn PW; He H; Wang Y; Wang Z; Guan G; Listman J; Perkins DL
J Immunol; 1997 May; 158(9):4074-81. PubMed ID: 9126965
[TBL] [Abstract][Full Text] [Related]
11. CTLA-4 interacts with STAT5 and inhibits STAT5-mediated transcription.
Srahna M; Van Grunsven LA; Remacle JE; Vandenberghe P
Immunology; 2006 Mar; 117(3):396-401. PubMed ID: 16476059
[TBL] [Abstract][Full Text] [Related]
12. CD28/CTLA-4--CD80/CD86 and ICOS--B7RP-1 costimulatory pathway in bronchial asthma.
Chen YQ; Shi HZ
Allergy; 2006 Jan; 61(1):15-26. PubMed ID: 16364152
[TBL] [Abstract][Full Text] [Related]
13. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with B-cell chronic lymphocytic leukemia in the Polish population.
Suwalska K; Pawlak E; Karabon L; Tomkiewicz A; Dobosz T; Urbaniak-Kujda D; Kuliczkowski K; Wolowiec D; Jedynak A; Frydecka I
Hum Immunol; 2008 Mar; 69(3):193-201. PubMed ID: 18396212
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of expression patterns of feline CD28 and CTLA-4 in feline immunodeficiency virus (FIV)-infected and FIV antigen-induced PBMC.
Choi IS; Yoo HS; Collisson EW
J Vet Sci; 2000 Dec; 1(2):97-103. PubMed ID: 14614304
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of plasma and cell surface co-stimulatory molecules CTLA-4, CD28 and CD86 in adult patients with allergic asthma.
Wong CK; Lun SW; Ko FW; Ip WK; Hui DS; Lam CW
Clin Exp Immunol; 2005 Jul; 141(1):122-9. PubMed ID: 15958078
[TBL] [Abstract][Full Text] [Related]
16. Schistosoma mansoni PIII antigen modulates in vitro granuloma formation by regulating CD28, CTLA-4, and CD86 expression in humans.
Zouain CS; Falcão PL; Goes TS; Leite MF; Goes AM
Immunol Lett; 2004 Feb; 91(2-3):113-8. PubMed ID: 15019278
[TBL] [Abstract][Full Text] [Related]
17. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2.
Tai X; Cowan M; Feigenbaum L; Singer A
Nat Immunol; 2005 Feb; 6(2):152-62. PubMed ID: 15640801
[TBL] [Abstract][Full Text] [Related]
18. Surface CD152 (CTLA-4) expression and signaling dictates longevity of CD28null T cells.
Hoff H; Knieke K; Cabail Z; Hirseland H; Vratsanos G; Burmester GR; Jorch G; Nadler SG; Bröker B; Hebel K; Brunner-Weinzierl MC
J Immunol; 2009 May; 182(9):5342-51. PubMed ID: 19380781
[TBL] [Abstract][Full Text] [Related]
19. Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells.
Habib-Agahi M; Phan TT; Searle PF
Int Immunol; 2007 Dec; 19(12):1383-94. PubMed ID: 17977894
[TBL] [Abstract][Full Text] [Related]
20. Dietary eicosapentaenoic acid modulates CTLA-4 expression in murine CD4+ T-cells.
Ly LH; Smith R; Switzer KC; Chapkin RS; McMurray DN
Prostaglandins Leukot Essent Fatty Acids; 2006 Jan; 74(1):29-37. PubMed ID: 16221546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
